Evorx Technologies, Inc.
- UEI
- WNVVQU8HYNT1
- CAGE
- 6N8J2
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of supr peptides as pet imaging agents for HER2+ breast cancer | National Cancer Institute | $2,002,936 | |
| Evorx technologies, INC:1233362 [15-068336] | National Cancer Institute | $299,990 | |
| Sbir phase i topic 324 project titled: novel molecular imaging agents for HER2+ breast cancer | National Cancer Institute | $249,748 |
Quick answers
What is Evorx Technologies, Inc.'s UEI?
Evorx Technologies, Inc.'s Unique Entity ID (UEI) in SAM.gov is WNVVQU8HYNT1.
What is Evorx Technologies, Inc.'s CAGE code?
Evorx Technologies, Inc.'s CAGE code is 6N8J2.
What is Evorx Technologies, Inc.'s primary NAICS code?
Evorx Technologies, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Is Evorx Technologies, Inc. registered in SAM.gov?
Evorx Technologies, Inc.'s SAM.gov registration expired on January 4, 2019.
What is Evorx Technologies, Inc.'s most recent federal award?
Evorx Technologies, Inc.'s most recent federal grant award is Development of supr peptides as pet imaging agents for HER2+ breast cancer (R44CA206771), from National Cancer Institute, on May 6, 2016.
On GovTribe
See Evorx Technologies, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors